Lathrop GPM LLP
Pharmaceutical composition comprising Pistacia weinmannifolia extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD)
The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-α, or MIP-2. In addition, due to the use of a safety-proven herbal drug as a raw material, the composition of the present invention can resolve various side-effects of existing therapeutic agents for COPD, chronic obstructive bronchitis, chronic bronchiolitis, emphysema, multiple sclerosis, and acute and chronic inflammation, and thus can be effectively used as a composition for preventing, treating and remedying COPD.
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
A A A A A A A A A A A A
A61K A61K A61K A61K A61P A61P A61P A23L A61P A61P A61P A23V
inventional inventional inventional additional inventional additional inventional inventional inventional inventional inventional additional
In Sik Kyung Seop Jung Hee Seung Hyung Sang Ho Sang Woo Sei Ryang Joong Ku Hang Wan Yi Hyung Won
Shin Ahn Kim Kim Choi Lee Oh Lee Jin Li Ryu